Cart
sales@molnova.com
JNJ-63533054
CAS No. 1802326-66-4
JNJ-63533054 ( JNJ 63533054; JNJ63533054; JNJ-63533054 )
Catalog No. M17383 CAS No. 1802326-66-4
JNJ-63533054 is a potent and selective agonist of hGPR139 with an EC50 = 16 nM.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 54 | In Stock |
|
| 10MG | 82 | In Stock |
|
| 25MG | 176 | In Stock |
|
| 50MG | 311 | In Stock |
|
| 100MG | 461 | In Stock |
|
| 500MG | 972 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJNJ-63533054
-
NoteResearch use only, not for human use.
-
Brief DescriptionJNJ-63533054 is a potent and selective agonist of hGPR139 with an EC50 = 16 nM.
-
DescriptionJNJ 63533054 is a potent and selective GPR139 agonist (EC50 = 16 nM) that is brain and cell penetrant. JNJ 63533054 is selective for GPR139 over a panel of GPCRs, ion channels and transporters, including GPR142 and is orally bioavailable.
-
SynonymsJNJ 63533054; JNJ63533054; JNJ-63533054
-
PathwayAngiogenesis
-
TargetAdrenergic Receptor
-
RecptorhGPR139
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number1802326-66-4
-
Formula Weight316.78
-
Molecular FormulaC17H17ClN2O2
-
Purity98%
-
SolubilityDMSO : ≥ 50 mg/mL 157.84 mM; H2O : < 0.1 mg/mL
-
SMILESC[C@@H](c1ccccc1)NC(=O)CNC(=O)c1cc(ccc1)Cl
-
Chemical Name3-Chloro-N-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dvorak CA, et al. ACS Med Chem Lett. 2015 Jul 20;6(9):1015-8.
molnova catalog
related products
-
Coelenterazine
Coelenterazine is a luminescent enzyme substrate, used for monitoring reporter genes in BRET, ELISA and HTS techniques.
-
BI 167107
BI 167107 is a highly potent agonist of the β2 adrenergic receptor (β2AR) and β1AR (IC50=3.2 nM) and shows some activity as α1A antagonist (IC50 = 32 nM).
-
Lutein
Lutein has antitumour action, is potentially useful for treating macular degeneration.
